Rebecca Torrence
@rebeccatorrenc5
Correspondent covering healthcare startups+VC @BusinessInsider👩🏻🔬 Send tips to [email protected] or Signal (423)987-0320
ID: 1270044807256211456
08-06-2020 17:27:41
279 Tweet
2,2K Takipçi
507 Takip Edilen
We got the deck Jonathan Bush used to land $40 million for Zus Health. Feat. a video of him pitching to VCs: "Athena, who's your daddy? It's Zus!" Bush said. "It's the next iteration of an original idea to get the internet to work in healthcare." businessinsider.com/pitch-deck-jon…
NEW for Business Insider: Pharmacy startups like Capsule and Truepill have landed heaps of investor cash to disrupt giants like CVS. Now, they're cutting employees or shutting down altogether. Experts told me these companies are running out of options. businessinsider.com/pharmacy-start…
Healthcare startups are fighting to get in on the new market for trendy weight loss drugs like Ozempic. Shelby Livingston and I broke down the 13 companies you need to know: businessinsider.com/venture-backed…
.Rebecca Torrence spoke with Hims CEO andrewdudum about whether the now-profitable digital health company is going to start prescribing buzzy weight-loss meds like Ozempic. He explained his reservations, and why Hims isn't jumping in just yet: businessinsider.com/hims-hers-glp-…
NEW: Healthcare companies are starting to prescribe trendy weight loss drugs like Ozempic and Wegovy online. But digital health pioneer Hims & Hers won't offer GLP-1s just yet. Here's what CEO andrewdudum is worried about in the emerging market: businessinsider.com/hims-hers-glp-…
Truepill, the startup that once powered prescriptions for digital health's hottest startups, is trying to reinvent itself after a messy 2022. The company is closing pharmacies as its customer base shrinks. New from Blake Dodge and I: businessinsider.com/inside-the-cha…
It's that time again! We're seeking nominations for Business Insider's annual list of the 30 leaders under 40 who are transforming healthcare: businessinsider.com/insider-30-und…
NEW: Louisiana's former health secretary started Nest Health to provide in-home primary care to families in her home state. Here's the pitch deck she used to land a $15 million seed round: businessinsider.com/pitch-deck-nes…
New from me and Rebecca Torrence. Ro’s weight-loss program is off to a bumpy start, with patients complaining about a variety of delays that go beyond drug shortages. businessinsider.com/ro-weight-loss…
NEW: Ro's weight-loss program could be its fastest growing business ever. But communication delays, a Wegovy shortage, and insurance woes are testing the bet — and leaving some patients feeling scammed. With Blake Dodge: businessinsider.com/ro-weight-loss…
This year's list of the most promising startups in healthtech is here! We asked VCs to name companies they'd invested in, as well as ones they hadn't. Check out their 16 picks: w/ Samantha Stokes businessinsider.com/vcs-most-promi…
Calibrate, one of the earliest startups to treat obesity with drugs like Wegovy, is struggling with loads of customer complaints and millions in refunds. In March alone, refunds totaled $2.6M, 60% of its D2C sales that month. From me and Rebecca Torrence businessinsider.com/weight-loss-st…
Calibrate, a weight-loss startup that prescribes drugs like Ozempic online, is staring at a mountain of patient complaints. The startup bled millions of dollars in refunds in the first half of 2023, including $2.6 million in March alone. w/ Shelby Livingston: businessinsider.com/weight-loss-st…
SCOOP! Madryn Asset Management gave weight-loss startup Calibrate two choices: either take a $20 million buyout from the private equity firm, or declare bankruptcy. w/ Shelby Livingston: businessinsider.com/calibrate-deal…
Scoop from last night! Here's how a PE firm took a 70% stake in weight-loss startup Calibrate for just $20 million. The deal terms are especially bleak for a startup that raised about $170 million from VC investors. with Rebecca Torrence businessinsider.com/calibrate-deal…